At a glance
ClinicalIndex Comparison RecordN/ACompleted· 20 enrolled
Drug / intervention
Electro-acupuncturedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Single-Arm Pilot Study of the Feasibility and Efficacy of Electro-Acupuncture in Subjects With Chemotherapy-Induced Peripheral Neuropathy
In Brief
A clinical study evaluating Electro-acupuncture for Chemotherapy-induced Peripheral Neuropathy. Completed, enrolled 20 participants across 1 site.
Detailed Summary
This study will determine the feasibility and efficacy of a 10-treatment electro-acupuncture (EA) program in subjects with chemotherapy-induced peripheral neuropathy (CIPN). The Investigators hypothesize that EA will be a feasible and effective therapy for CIPN.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2020202120222023202420252026
Enrollment StartAug 2019
Primary CompletionAug 2023
First PostedMar 2026
TodayJul 2026
First PostedMar 6, 2026
Enrollment StartAug 29, 2019
Primary CompletionAug 18, 2023
TodayJul 2, 2026
Enrollment to primary: 4.0 yearsPosted 4 months ago
Interventions
Electro-acupuncturedevice
Electro-acupuncture (EA) is a non-pharmacologic treatment that combines traditional acupuncture with electrical stimulation and involves passing a small electrical current between pairs of acupuncture needles.